Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 13th:
Ferrari N.V. (RACE - Free Report) : This luxury sports cars manufacturer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.9% over the last 60 days.
Ferrari’s shares gained 12.5% over the last one month against the S&P 500’s rise of 5.2%. The company possesses a Momentum Score of B.
Varian Medical Systems, Inc. : This medical devices and software products manufacturer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
Varian Medical Systems’s shares gained 6.6% over the last one month. The company possesses a Momentum Score of B.
Forterra, Inc. : This water and drainage pipe and products manufacturer has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.8% over the last 60 days.
Forterra’s shares gained 9% over the last one month. The company possesses a Momentum Score of A.
Dell Technologies Inc. (DELL - Free Report) : This manufacturer and supporter of information technology products and services has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
Dell Technologies’ shares gained 24.6% over the last one month. The company possesses a Momentum Score of B.
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 13th:
Ferrari N.V. (RACE - Free Report) : This luxury sports cars manufacturer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.9% over the last 60 days.
Ferrari’s shares gained 12.5% over the last one month against the S&P 500’s rise of 5.2%. The company possesses a Momentum Score of B.
Varian Medical Systems, Inc. : This medical devices and software products manufacturer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
Varian Medical Systems’s shares gained 6.6% over the last one month. The company possesses a Momentum Score of B.
Forterra, Inc. : This water and drainage pipe and products manufacturer has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.8% over the last 60 days.
Forterra’s shares gained 9% over the last one month. The company possesses a Momentum Score of A.
Dell Technologies Inc. (DELL - Free Report) : This manufacturer and supporter of information technology products and services has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
Dell Technologies’ shares gained 24.6% over the last one month. The company possesses a Momentum Score of B.
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on DELL - FREE
Get the latest research report on RACE - FREE